Lee Cranmer, MD
Fred Hutch/University of Washington Cancer Consortium · University of Arizona · The University of Arizona Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lee Cranmer, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:26 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04220229 · Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the ExtremitiesUniversity of Washington · terminated · Sarcoma of the Extremity, Stage I Soft Tissue Sarcoma of the Trunk and Extremities, Stage IA Soft Tissue Sarcoma of the Trunk and Extremities · principal investigator
- Ph1/Ph2NCT03660930 · Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue SarcomasUniversity of Washington · terminated · Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma · principal investigator
- Ph1/Ph2NCT02065466 · Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain MetastasesUniversity of Arizona · withdrawn · Metastatic Melanoma, Brain Metastases · principal investigator
- Ph2NCT02050321 · A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced MelanomaUniversity of Arizona · terminated · Malignant Melanoma · principal investigator
- Ph1NCT02020226 · A Cardiac Safety Study of TH-302 in Patients With Advanced Solid TumorsThreshold Pharmaceuticals · unknown · Solid Tumors · principal investigator
- Ph1NCT01172028 · Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsUniversity of Arizona · completed · Breast Cancer, Esophageal Cancer, Gastric Cancer · principal investigator
- Ph2NCT00441467 · Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue SarcomaEleison Pharmaceuticals LLC. · completed · Soft Tissue Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Biology Program (CBP)P30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Koenraad Van Doorslaer · fiscal years 1999 to 2026Named on NCT01172028
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.